Industry News
Advanced manufacturing heading overseas, says survey
AusBiotech has released the results of the Biotechnology Industry Position Survey (2014). The survey finds that advanced manufacturing associated with the biotech industry is following traditional manufacturing and heading overseas. [ + ]
Eucalyptus genome sequenced
Initial results of the Eucalyptus genome sequence have been revealed. [ + ]
Phosphagenics employees plead guilty over fraud
A hearing into the alleged fraud against Phosphagenics has resulted in two men pleading guilty to issuing false invoices worth millions of dollars. [ + ]
LBT Innovations gets $1m milestone payment
LBT Innovations' (ASX:LBT) partner in the JV set up to oversee the development of its Automated Plate Assessment System has paid out a third $1m milestone payment. [ + ]
Thermo Fisher Scientific and BioAnalytix collaborate on biopharmaceutical analysis workflows
Scientists at Thermo Fisher Scientific and BioAnalytix are combining their expertise to develop advanced analytical profiling platforms and applications to characterise biologic and biosimilar drugs. [ + ]
NHMRC awards for excellence
This year's National Health and Medical Research Council's prizes for excellence in health and medical research have been announced. [ + ]
Peter Klinken appointed Chief Scientist of WA
WA Premier and Minister for Science Colin Barnett has announced Professor Peter Klinken as the new Chief Scientist of Western Australia. Professor Klinken is a leading medical researcher who is highly regarded for advancing the understanding of genes involved in leukaemia, cancer and anaemia. [ + ]
Genetic Technologies hires new CFO
Genetic Technologies' (ASX:GTG) new CFO, Eutillio Buccilli, has more than 35 years of senior management experience. [ + ]
Reconfiguring the link between GAD65 and diabetes
Another step has been taken in understanding the link between glutamic acid decarboxylase and type 1 diabetes. [ + ]
Outcome on employee share schemes expected mid-June
Treasury has confirmed that issues raised in submissions to its review of 'employee share schemes (ESS) and start-ups' will be considered by the Prime Minister's taskforce established to develop a National Industry Investment and Competitiveness Agenda, which is expected to be delivered in the coming weeks. [ + ]
Alchemia aims to report on mCRC trial in Q3
Alchemia (ASX:ACL) now expects top-line results from its phase III trial of HA-Irinotecan in colorectal cancer to be ready in Q3, and aims to file FDA and EMA submissions in 1H15. [ + ]
Optical sensor measures oxygen directly in cells and tissues
German biotechnology company ibidi has revealed a device that optically measures the exact oxygen content directly in cells and tissues. The ibidi OPAL Optical O2 Measurement System determines the correct O2 content, which is a critical factor in maintaining the natural behaviour of cells in culture. [ + ]
First burns patient treated in NovoSorb BTM trial
Calzada (ASX:CZD) revealed that the first burns patient enrolled in a clinical trial of its NovoSorb BTM has been successfully treated and is out of intensive care. [ + ]
Starpharma making progress with clinical trials
Starpharma (ASX:SPL) has dosed the first group of patients for a phase I trial of DEP docetaxel in solid tumours and commenced final preparations for a phase III trial of VivaGel for the prevention of BV recurrence. [ + ]
Macfarlane criticises Labor science policies
The Minister for Industry, Ian Macfarlane, has claimed that the former Labor government's science policies "made no provision for the ongoing costs of science and research", according to Senate estimates. [ + ]
